1. Pitout JD. Infections with extended-spectrum beta-lactamaseproducing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs. 2010; 70:313–333.
2. Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis. 2011; 17:1791–1798.
3. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011; 53:60–67.
4. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009; 9:228–236.
Article
5. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012; 25:682–707.
6. Jeong SH, Song W, Bae IK, Kim HS, Kim JS, Park MJ, et al. Broth microdilution methods using B-lactamase inhibitors for the identification of Klebsiella pneumoniae carbapenemases and metallo-β-lactamases in Gram-negative bacilli. Ann Clin Lab Sci. 2014; 44:49–55.
7. Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol. 2007; 45:2723–2725.
8. Pasteran F, Mendez T, Rapoport M, Guerriero L, Corso A. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class a carbapenemase in species of enterobacteriaceae by incorporating boronic acid. J Clin Microbiol. 2010; 48:1323–1332.
Article
9. Yoon EJ, Yang JW, Kim JO, Lee H, Lee KJ, Jeong SH. Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the National Laboratory Surveillance System. Future Microbiol. 2018; 13:771–783.
10. Yoon EJ, Kim JO, Yang JW, Kim HS, Lee KJ, Jeong SH, et al. The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems. J Antimicrob Chemother. 2017; 72:2708–2714.
Article
11. Bush K. Alarming β-lactamase-mediated resistance in multidrugresistant Enterobacteriaceae. Curr Opin Microbiol. 2010; 13:558–564.
12. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009; 30:1180–1185.
Article
13. Park JW, Lee EJ, Lee DH. Status of carbapenemase producing Enterobacteriaceae in Korea, 2014. Public Health Wkly Rep. 2016; 9:9–13.
14. CLSI. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute;2013.
15. Doumith M, Ellington MJ, Livermore DM, Woodford N. Molecular mechanisms disrupting porin expression in ertapenemresistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother. 2009; 63:659–667.
Article
16. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011; 70:119–123.
Article
17. You JS. Emergence and characteristics of carbapenemase-producing Enterobacteriaceae (CPE) in Korea, 2012. Public Health Wkly Rep. 2013; 6:425–428.
18. Huang TD, Bogaerts P, Ghilani E, Heinrichs A, Gavage P, Roisin S, et al. Multicentre evaluation of the Check-Direct CPE® assay for direct screening of carbapenemase-producing Enterobacteriaceae from rectal swabs. J Antimicrob Chemother. 2015; 70:1669–1673.